However, combined treatment with creno and AZA effectively reduced stromal resistance of FLT3-ITD AML cells indicated by significant induction of cell death in the presence of stroma (Figure 3B) and positive interaction testing by linear regression analyses (complete statistical analyses in Supplementary data). The gene discussed is FLT3; the disease is acute myeloid leukemia.